A Review of Novel Nanosystems in EnhancingCell Death in Breast Cancer: Important Conclusion:s From Recent Advances
- سال انتشار: 1402
- محل انتشار: اولین کنگره بین المللی ژنومیک سرطان
- کد COI اختصاصی: CGC01_198
- زبان مقاله: انگلیسی
- تعداد مشاهده: 69
نویسندگان
Department of Chemistry, Amirkabir University of Technology,Tehran P.O. Box ۱۵۸۷۵-۴۴۱۳, Tehran, Iran
Department of Chemistry, Amirkabir University of Technology,Tehran P.O. Box ۱۵۸۷۵-۴۴۱۳, Tehran, Iran
Department of Polymer Engineering, Faculty of Engineering,South Tehran Branch, Islamic Azad University, P.O. Box: ۱۹۵۸۵-۴۶۶, Tehran, Iran
Department of Chemistry, Shahre-Qods Branch, Islamic AzadUniversity, Shahre-Qods ۳۷۵۱۵-۳۷۴, Tehran, Iran
Department of Polymer Engineering, Faculty of Engineering,South Tehran Branch, Islamic Azad University, P.O. Box: ۱۹۵۸۵-۴۶۶, Tehran, Iran
Department of Chemistry, Shahre-Qods Branch, Islamic AzadUniversity, Shahre-Qods ۳۷۵۱۵-۳۷۴, Tehran, Iran
چکیده
Nanotechnology-based drug delivery systems can reduce sideeffects, increase drug release time, and control drug release.Polymeric nanoparticles used as drug nanocarriers increasedrug solubility and stability. Growing concerns about the safetyof chemicals and additives have necessitated the use of bioactivesubstances. Drug concentration is an important factor incytotoxicity studies as it can play a role in cell death and growthinhibition. Thus, beneficial substances released by nanocarriersremove negative and unstable substances from cells. Nanocarriersare designed for prolonged release of drugs at the cancersite, resulting in potent cytotoxicity. In the most recent study,nanocarriers are prepared by double emulsion methods that stabilizeand fix the shape of the nanoparticles and also prevent thenanoparticles from accelerating during drug release in vivo. Inthis study, Cytotoxicity investigated the effect of a newly developednanocarrier on anti-inflammatory drug delivery to breastcancer cells(MCF-۷).کلیدواژه ها
Cell Death, Breast Cancer, Nanocarrier, Drug Releaseاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.